Corbus Pharmaceuticals Holding (CRBP) — Capital Reinvestment Ratio

Latest as of September 2021: 0.01x

Corbus Pharmaceuticals Holding (CRBP) has a Capital Reinvestment Ratio of 0.01x as of September 2021, meaning it reinvests 0% of its operating cash flow ($856.95K) in capital expenditures ($7.70K). Check how tangible is Corbus Pharmaceuticals Holding's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$856.95K

USD

Capital Expenditures

$7.70K

USD

Data as of

Sep 2021

Most recent filing

Annual Capital Reinvestment Ratio for Corbus Pharmaceuticals Holding (None–None)

Year-by-year Capital Reinvestment Ratio for Corbus Pharmaceuticals Holding from None to None. See CRBP free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow